| P50 | author | Stefania Chiappini | Q88459395 |
| | John Corkery | Q55128379 |
| P2093 | author name string | Fabrizio Schifano | |
| | Barbara Loi | |
| | Christine Goodair | |
| | Carla Gimeno Clemente | |
| | Hugh Claridge | |
| P2860 | cites work | Mephedrone (methylmethcathinone) in toxicology casework: a Northern Ireland perspective | Q85963858 |
| | Clinical characteristics of mephedrone toxicity reported to the U.K. National Poisons Information Service | Q24629270 |
| | Recreational use of mephedrone (4-methylmethcathinone, 4-MMC) with associated sympathomimetic toxicity | Q24631444 |
| | 1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors | Q24645072 |
| | Inhibition of plasma membrane monoamine transporters by beta-ketoamphetamines | Q28145996 |
| | Comparative neuropharmacology of three psychostimulant cathinone derivatives: butylone, mephedrone and methylone | Q28264655 |
| | Pharmacological characterization of designer cathinones in vitro | Q28273207 |
| | Mephedrone, new kid for the chop? | Q30392896 |
| | Using poisons information service data to assess the acute harms associated with novel psychoactive substances. | Q30821795 |
| | Overview of amphetamine-type stimulant mortality data--UK, 1997-2007. | Q33527227 |
| | Cathinone, a natural amphetamine | Q33977575 |
| | Multiple-drug toxicity caused by the coadministration of 4-methylmethcathinone (mephedrone) and heroin | Q34111094 |
| | Mephedrone (4-methylmethcathinone; 'meow meow'): chemical, pharmacological and clinical issues. | Q34149434 |
| | The pharmacology and toxicology of the synthetic cathinone mephedrone (4-methylmethcathinone). | Q34200334 |
| | Limited use of novel psychoactive substances in South London nightclubs. | Q34639475 |
| | A bitter pill. Overview of ecstasy (MDMA, MDA) related fatalities | Q35607159 |
| | New trends in the cyber and street market of recreational drugs? The case of 2C-T-7 ('Blue Mystic'). | Q36307104 |
| | Amphetamines as potential inducers of fatalities: a review in the district of Ghent from 1976-2004. | Q36384701 |
| | Pharmacological properties of the stimulant khat | Q37613050 |
| | Ivory wave: the next mephedrone? | Q37853280 |
| | Mephedrone (4-methylmethcathinone)-related deaths | Q42744621 |
| | Mephedrone: still available and twice the price | Q42833281 |
| | The detection of mephedrone (4-methylmethcathinone) in 4 fatalities in Scotland | Q42946688 |
| | UK places generic ban on mephedrone drug family | Q43092499 |
| | Mephedrone is an amphetamine "by another name," drug adviser tells MPs. | Q43119696 |
| | What should be done about mephedrone? | Q43120581 |
| | Monitoring trends in recreational drug use from the analysis of the contents of amnesty bins in gay dance clubs | Q43300039 |
| | A web-based survey on mephedrone | Q45421878 |
| | Suspected and confirmed fatalities associated with mephedrone (4-methylmethcathinone, "meow meow") in the United Kingdom | Q46486751 |
| | Chronic ketamine use increases serum levels of brain-derived neurotrophic factor | Q48304534 |
| | Internet use and misuse: a multivariate regression analysis of the predictive factors of internet use among Greek adolescents. | Q52293402 |
| | Tweaking, bombing, dabbing and stockpiling: the emergence of mephedrone and the perversity of prohibition | Q56446476 |
| | Emergency department presentations in determining the effectiveness of drug control in the United Kingdom: mephedrone (4-methylmethcathinone) control appears to be effective using this model | Q82242692 |
| P433 | issue | 4 | |
| P304 | page(s) | 225-232 | |
| P577 | publication date | 2015-07-01 | |
| P1433 | published in | Human Psychopharmacology | Q15751477 |
| P1476 | title | Deaths of individuals aged 16-24 years in the UK after using mephedrone | |
| P478 | volume | 30 | |